Our impasse in developing a malaria vaccine
Identifieur interne : 001531 ( Main/Exploration ); précédent : 001530; suivant : 001532Our impasse in developing a malaria vaccine
Auteurs : Michael F. Good [Australie]Source :
- Cellular and Molecular Life Sciences [ 1420-682X ] ; 2011-04-01.
Descripteurs français
- Wicri :
- topic : Vaccin.
English descriptors
- KwdEn :
Abstract
Abstract: Malaria presents a challenge to world health that to date has been beyond the abilities of researchers to conquer. This critique presents some of the strategies employed by the parasite to overcome immunity and the immunological challenges that we face to develop vaccines. A conclusion is that a vaccine must identify novel antigens or epitopes that are not normally immunogenic and which are therefore not under immune pressure and most likely to be conserved between different strains. Such antigens are most likely to be targets of cellular immunity. The case for a whole parasite blood stage vaccine is presented based on these premises.
Url:
DOI: 10.1007/s00018-011-0634-5
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001E16
- to stream Istex, to step Curation: 001E16
- to stream Istex, to step Checkpoint: 000507
- to stream Main, to step Merge: 001533
- to stream Main, to step Curation: 001531
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Our impasse in developing a malaria vaccine</title><author><name sortKey="Good, Michael F" sort="Good, Michael F" uniqKey="Good M" first="Michael F." last="Good">Michael F. Good</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:198D549DC2E81E42F3DA50C680792C0F1B21411F</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1007/s00018-011-0634-5</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-V24KNH1T-7/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001E16</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001E16</idno><idno type="wicri:Area/Istex/Curation">001E16</idno><idno type="wicri:Area/Istex/Checkpoint">000507</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000507</idno><idno type="wicri:doubleKey">1420-682X:2011:Good M:our:impasse:in</idno><idno type="wicri:Area/Main/Merge">001533</idno><idno type="wicri:Area/Main/Curation">001531</idno><idno type="wicri:Area/Main/Exploration">001531</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Our impasse in developing a malaria vaccine</title><author><name sortKey="Good, Michael F" sort="Good, Michael F" uniqKey="Good M" first="Michael F." last="Good">Michael F. Good</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Institute for Glycomics, Gold Coast Campus, Griffith University, 4222, Gold Coast, QLD</wicri:regionArea><wicri:noRegion>QLD</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Australie</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Cellular and Molecular Life Sciences</title><title level="j" type="abbrev">Cell. Mol. Life Sci.</title><idno type="ISSN">1420-682X</idno><idno type="eISSN">1420-9071</idno><imprint><publisher>SP Birkhäuser Verlag Basel</publisher><pubPlace>Basel</pubPlace><date type="published" when="2011-04-01">2011-04-01</date><biblScope unit="volume">68</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="1105">1105</biblScope><biblScope unit="page" to="1113">1113</biblScope></imprint><idno type="ISSN">1420-682X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1420-682X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Immune response</term><term>Malaria</term><term>Natural immunity</term><term>Vaccine</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Vaccin</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Malaria presents a challenge to world health that to date has been beyond the abilities of researchers to conquer. This critique presents some of the strategies employed by the parasite to overcome immunity and the immunological challenges that we face to develop vaccines. A conclusion is that a vaccine must identify novel antigens or epitopes that are not normally immunogenic and which are therefore not under immune pressure and most likely to be conserved between different strains. Such antigens are most likely to be targets of cellular immunity. The case for a whole parasite blood stage vaccine is presented based on these premises.</div></front></TEI><affiliations><list><country><li>Australie</li></country></list><tree><country name="Australie"><noRegion><name sortKey="Good, Michael F" sort="Good, Michael F" uniqKey="Good M" first="Michael F." last="Good">Michael F. Good</name></noRegion><name sortKey="Good, Michael F" sort="Good, Michael F" uniqKey="Good M" first="Michael F." last="Good">Michael F. Good</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001531 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001531 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:198D549DC2E81E42F3DA50C680792C0F1B21411F
|texte= Our impasse in developing a malaria vaccine
}}
| This area was generated with Dilib version V0.6.33. |  |